EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes

The Medical Letter on Drugs and Therapeutics · 2024

DOI: 10.58347/tml.2024.1708c ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Medical Letter on Drugs and Therapeutics, 2024. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptide 1, Hypoglycemic Agents, Gastric Inhibitory Polypeptide.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Glucagon-Like Peptide 1Hypoglycemic AgentsGastric Inhibitory PolypeptideGlucagon-Like Peptide-1 Receptor AgonistsHumansReceptors, Gastrointestinal HormoneAnimalsGlucagon-Like Peptide-1 Receptor

Stichwörter der Autor:innen

Bydureon BCiseByettaMounjaroOzempicRybelsusTrulicityVictozaadverse effectsdosagedrug interactionsdulaglutideexenatidelactationliraglutidepregnancy

Substanzen

Glucagon-Like Peptide 1Hypoglycemic AgentsGastric Inhibitory PolypeptideReceptors, Gastrointestinal HormoneGlucagon-Like Peptide-1 Receptor AgonistsGLP1R protein, humanGlucagon-Like Peptide-1 Receptorgastric inhibitory polypeptide receptor

Zitieren

APA

(2024). Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes. The Medical Letter on Drugs and Therapeutics. https://doi.org/10.58347/tml.2024.1708c

Vancouver

Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes. The Medical Letter on Drugs and Therapeutics. 2024. doi:10.58347/tml.2024.1708c

BibTeX
@article{euvimed2024,
  title = {Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes},
  journal = {The Medical Letter on Drugs and Therapeutics},
  year = {2024},
  doi = {10.58347/tml.2024.1708c}
}
Kostenlos starten →